My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

176.51 -0.18 (-0.10%)
Streaming Delayed Price Updated: 11:05 AM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,754,291
Open 177.20
Bid (Size) 176.50 (1)
Ask (Size) 176.54 (2)
Prev. Close 176.69
Today's Range 176.40 - 178.40
52wk Range 140.68 - 181.16
Shares Outstanding 2,628,679,824
Dividend Yield 2.95%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
US Stocks Grapple with Quarter-End Jitters, Two-Day Losing Streak Tests Market Resolve
New York, NY – September 25, 2025 – As the third quarter of 2025 rapidly approaches its conclusion, U.S. stock markets are navigating a challenging period, marked by a two-day losing streak that... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Market Tremors: Dow, S&P 500, and Nasdaq Endure Third Straight Day of Losses Amidst Economic Headwinds
New York, NY – September 25, 2025 – Major U.S. stock indices, including the Dow Jones Industrial Average, the S&P 500, and the Nasdaq Composite, have registered their third consecutive day of declines,... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks

Performance

YTD
+22.6%
+22.6%
1 Month
-1.1%
-1.1%
3 Month
+15.9%
+15.9%
6 Month
+9.1%
+9.1%
1 Year
+8.4%
+8.4%

More News

Read More
Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullish
Via Stocktwits
Topics Government
Johnson & Johnson (NYSE:JNJ) Shows Strong Technical Setup for Potential Breakout
Via Chartmill
These 3 Dow Stocks Are Set to Soar in 2025 and Beyond
Via The Motley Fool
Topics Artificial Intelligence Stocks
3 Exceptional High-Yielding Dividend Kings That Have Been Increasing Their Payouts for Over 60 Years
Via The Motley Fool
Topics Economy
Kenvue Bounces Off Record Low: A Deep Dive into its Rebound and Future Prospects
Via MarketMinute
Topics Government Product Recall
Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies
Via Benzinga
Johnson & Johnson Is Attacking 2022 Highs
Via Talk Markets
Trump’s Tylenol Warning Sparks FDA Action, But Kenvue Stock Climbs: Retail Traders See ‘Huge Buying Opportunity’
Via Stocktwits
Topics Economy Government Lawsuit
The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning
Via Benzinga
Jabil Set For Major AI Growth As Other Segments Falter: Analyst
Via Benzinga
Topics Artificial Intelligence
Evolving Investment Strategies for an Uncertain Market
Via MarketMinute
Topics Bonds ETFs Economy
This Johnson & Johnson Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Johnson & Johnson Ends Overseas Sales Of Acid Reflux Device Citing Market Factors
Via Benzinga
Beyond The Numbers: 10 Analysts Discuss Johnson & Johnson Stock
Via Benzinga
The Ultimate Dividend King Drug Stock to Buy With $1,000 Right Now
Via The Motley Fool
Jim Cramer Says Trump Is Creating 'A Nightmare' For Kenvue As President Links Tylenol With Autism
Via Benzinga
Topics Government Lawsuit
Johnson & Johnson Stock Weathers Trump’s Tylenol Attacks Better Than Kenvue Amid Dipping Retail Confidence — What’s Holding Losses in Check?
Via Stocktwits
Topics Government
U.S. Government Shutdown Looms: A Guide for Investors Navigating Political and Economic Uncertainty
Via MarketMinute
Topics Bonds Economy
Kenvue Stock Sinks To Record Low As Trump To Reportedly Link Tylenol Use To Autism
Via Talk Markets
Topics Government
The Enduring Appeal of Dividend Aristocrats: A Beacon of Stability in Turbulent Markets
Via MarketMinute
Topics ETFs Economy Energy
The Unyielding Power of Dividends: A Blueprint for Enduring Wealth
Via MarketMinute
Topics Retirement Supply Chain
Growth Titans: Eli Lilly's Weight-Loss Surge vs. Johnson & Johnson's Diversified Might
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 176.51
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 09/25/25 11:05 AM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 463.99B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 464B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.